☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
C. Difficile Infection
Seres Therapeutics and Nestlé Health Science Receive the US FDA’s Approval of VOWST for the Prevention of Recurrence of C. Diffici...
April 27, 2023
Pfizer Reports Results of Clostridioides Difficile Vaccine in P-III (CLOVER) Trial for the Prevention of C. Difficile Infection
March 2, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.